CSPAN2 Key Capitol Hill Hearings November 6, 2014
Sector. They are actively engaged in the process and the followon when you talk about a prime boost and the major vaccine, the boost being of followon in other Large Pharma Companies but they invested time and resources and opportunity. And that vaccine shows efficacy. And very much the Public Sector, and very clear this was public good. And the polio vaccines, certainly we expect the lions share of Product Development costs by Public Sectors that would be an equitable one. It comes through investment, engage in the product prices. We get into Licensing Agreements that is part of the licensing...
Source: archive.org